Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending October 09, 2006. The report serves as a notification of transactions involving Directors, Persons Discharging Managerial Responsibility, or Connected Persons regarding their interests in the company's Ordinary Shares.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is strictly a regulatory disclosure of share transactions and does not contain financial performance data.
Material Changes
The filing details the acquisition of Ordinary Shares by six individuals through the Company's ShareReward Plan on October 05, 2006. The shares were purchased at a price of GBP14.45 per Ordinary Share under the Dividend Reinvestment element of the Plan, which was entered into on October 05, 2001. The specific acquisitions were:
- Mr J S Heslop: 9 Ordinary Shares
- Mr R Bondy: 9 Ordinary Shares
- Mr D Learmouth: 9 Ordinary Shares
- Dr D Pulman: 6 Ordinary Shares
- Mr C Viehbacher: 2 Ordinary Shares
- Mr A P Witty: 9 Ordinary Shares
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document is limited to the notification of the aforementioned share transactions in accordance with Disclosure Rules 3.1.4R(1)(a) and 3.1.4R(1)(b).
Key Facts for Investor Verification
- Transaction Date: October 05, 2006
- Share Price: GBP14.45 per Ordinary Share
- Plan Type: ShareReward Plan (Dividend Reinvestment element)
- Total Shares Acquired by Listed Individuals: 44 Ordinary Shares
- Notification Date: October 06, 2006